Domestic Health Insurance and Pharmaceutical Policy

New legislative and regulatory initiatives continually shape the US health policy environment.  Policy changes, such as, new health insurance benefit limits or expansions, are intended to guard against overuse of health services control costs, or improve access and quality of healthcare. However, many new policies are not based on convincing evidence of their efficacy in achieving these objectives.

Over the last two decades, DPM's Division of Health Policy and Insurance Research (HPI) has conducted seminal research evaluating the affordability of health care and medications and the impacts of interventions to improve clinical care or reduce costs.  In addition to publishing the results of these research studies in the medical literature, the group has worked closely with national and state policymakers as well as non-governmental health agencies to translate their research findings into improved health policies.  

More detail on our past research and impacts are available here.  Our current major areas of research focus are described in additional detail at the following links:


Impacts on Domestic Health Policies




Health Insurance Innovation and Health Reform


Effects of Pharmacy Benefit Limits and Expansions


Affordability and Burden of Medical and Pharmaceutical Costs


Interventions in Clinical Care


Mental Health Treatment


Improving the Quality of Clinical and Health Policy Research


Cancer Care Delivery and Policy


Impacts of DPRG on US Health Policies